Viral vectors for the expression of proteins in plants
- PMID: 17368018
- DOI: 10.1016/j.copbio.2007.03.002
Viral vectors for the expression of proteins in plants
Abstract
The use of plant viral vectors for the transient expression of heterologous proteins offers a useful tool for the large-scale production of proteins of industrial importance, such as antibodies and vaccine antigens. In recent years, advances have been made both in the development of first-generation vectors (that employ the 'full virus') and second-generation ('deconstructed virus') vectors. For example, vectors based around the 'full virus' strategy can now be used to express long polypeptides (at least 140 amino acids long) as fusions to the coat protein. In addition, a new generation of vectors was engineered to have a reactogenic amino acid exposed on the surface of the virus, allowing easy chemical conjugation of (separately produced) proteins to the viral surface. This approach is being used to develop new vaccines in the form of antigens coupled to a plant viral surface. Prototypes of industrial processes that require high-yield production, rapid scale-up, and fast manufacturing have been recently developed using the 'deconstructed virus' approach (magnifection). This process, which relies on Agrobacterium as a vector to deliver DNA copies of one or more viral RNA replicons to plant cells, has been shown to work with numerous proteins, including full immunoglobulin G antibodies. Other advances in this area have looked at the development of inducible viral systems and the use of viral vectors to produce nanoscale materials for modular assembly.
Similar articles
-
Engineering viral expression vectors for plants: the 'full virus' and the 'deconstructed virus' strategies.Curr Opin Plant Biol. 2004 Apr;7(2):182-8. doi: 10.1016/j.pbi.2004.01.003. Curr Opin Plant Biol. 2004. PMID: 15003219 Review.
-
Magnifection--a new platform for expressing recombinant vaccines in plants.Vaccine. 2005 Mar 18;23(17-18):2042-8. doi: 10.1016/j.vaccine.2005.01.006. Vaccine. 2005. PMID: 15755568 Review.
-
Plant viral vectors for delivery by Agrobacterium.Curr Top Microbiol Immunol. 2014;375:155-92. doi: 10.1007/82_2013_352. Curr Top Microbiol Immunol. 2014. PMID: 23949286 Review.
-
High-yield production of authentic human growth hormone using a plant virus-based expression system.Plant Biotechnol J. 2005 Nov;3(6):613-20. doi: 10.1111/j.1467-7652.2005.00154.x. Plant Biotechnol J. 2005. PMID: 17147632
-
Infectious full-length clones of plant viruses and their use for construction of viral vectors.Acta Virol. 2007;51(4):223-37. Acta Virol. 2007. PMID: 18197730 Review.
Cited by
-
Plant-based oral vaccines against zoonotic and non-zoonotic diseases.Plant Biotechnol J. 2016 Nov;14(11):2079-2099. doi: 10.1111/pbi.12604. Epub 2016 Aug 23. Plant Biotechnol J. 2016. PMID: 27442628 Free PMC article. Review.
-
A randomized, double-blind, placebo-controlled, dose-escalating phase I trial to evaluate safety and immunogenicity of a plant-produced, bivalent, recombinant norovirus-like particle vaccine.Front Immunol. 2022 Oct 7;13:1021500. doi: 10.3389/fimmu.2022.1021500. eCollection 2022. Front Immunol. 2022. PMID: 36275772 Free PMC article. Clinical Trial.
-
Plant Molecular Farming: A Viable Platform for Recombinant Biopharmaceutical Production.Plants (Basel). 2020 Jul 4;9(7):842. doi: 10.3390/plants9070842. Plants (Basel). 2020. PMID: 32635427 Free PMC article. Review.
-
A comparative analysis of recombinant protein expression in different biofactories: bacteria, insect cells and plant systems.J Vis Exp. 2015 Mar 23;(97):52459. doi: 10.3791/52459. J Vis Exp. 2015. PMID: 25867956 Free PMC article.
-
Transient expression of anti-VEFGR2 nanobody in Nicotiana tabacum and N. benthamiana.3 Biotech. 2018 Dec;8(12):484. doi: 10.1007/s13205-018-1500-z. Epub 2018 Nov 15. 3 Biotech. 2018. PMID: 30467531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources